Key result
Novel MPV*NLR/PLT index predicts acute ischemic stroke and TIA severity with ~0.72 admission AUC.
Cohort (n=104)
BACKGROUND: It is still not easy to predict severity promptly in patients with acute ischemic stroke (AIS) and transient ischemic attack (TIA). We investigated that platelet parameters or combinations of them could be a useful tool for early prediction of severity of AIS and TIA at admission and after 3 months. METHODS: We prospectively recruited 104 patients newly diagnosed with AIS and TIA. We investigated their neutrophil-to-lymphocyte ratio (NLR) and platelet parameters. According to the Modified Rankin Scale scores, the patients were divided into two groups. RESULTS: In receiver operating characteristic (ROC) curve analyses, mean platelet volume (MPV), NLR/platelet count (PLT), MPV/PLT, MPV*NLR, and MPV*NLR/PLT showed statistically significant results in both at admission and after 3 months. Values of area under ROC curves for those tests at admission were 0.646, 0.697, 0.664, 0.708, and 0.722, respectively. Also, values after 3 months were 0.591, 0.661, 0.638, 0.662, and 0.689, respectively. CONCLUSION: MPV*NLR/PLT could be used as a relatively good tool for predicting severity at the time of admission and after 3 months than other parameters or combinations of them. Further studies have to be carried out to investigate the best parameter for predicting the severity of AIS and TIA.
No takes yet. Share an insight, caveat, or question.
Lim et al. (2018) conducted a cohort in Acute ischemic stroke and transient ischemic attack (n=104). Platelet parameters and neutrophil-to-lymphocyte ratio (NLR) was evaluated on Severity of AIS and TIA at admission and after 3 months according to the Modified Rankin Scale scores (AUC 0.722 at admission and 0.689 at 3 months for MPV*NLR/PLT). The combination parameter MPV*NLR/PLT effectively predicted the severity of acute ischemic stroke and TIA at admission (AUC 0.722) and after 3 months (AUC 0.689).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: